| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5586886 | Cytokine | 2017 | 11 Pages |
Abstract
Our results suggest a role for prostatic expression of TGF-B, IL-1a, TGFBRI and TGFBRII as prognostic markers for prostate cancer. The rational combination of novel agents directed toward the inactivation of TGF-B, IL-1a, TGFBRI and TGFBRII could disrupt complementary tumor cell proliferation pathways.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Norelia Torrealba, Gonzalo RodrÃguez-Berriguete, Benito Fraile, Gabriel Olmedilla, Pilar MartÃnez-Onsurbe, Manuel Guil-Cid, Ricardo Paniagua, Mar Royuela,